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Abstract
Functionalization of tissue engineering scaffolds with in vitro–generated bone-like extracellular matrix (ECM)
represents an effective biomimetic approach to promote osteogenic differentiation of stem cells in vitro. How-
ever, the bone-forming capacity of these constructs (seeded with or without cells) is so far not apparent. In this
study, we aimed at developing a mineralizing culture condition to biofunctionalize three-dimensional (3D) po-
rous scaffolds with highly mineralized ECM in order to produce devitalized, osteoinductive mineralized carriers
for human periosteal-derived progenitors (hPDCs). For this, three medium formulations [i.e., growth medium
only (BM1), with ascorbic acid (BM2), and with ascorbic acid and dexamethasone (BM3)] supplemented
with calcium (Ca2+ ) and phosphate (PO4
3) ions simultaneously as mineralizing source were investigated.
The results showed that, besides the significant impacts on enhancing cell proliferation (the highest in BM3 con-
dition), the formulated mineralizing media differentially regulated the osteochondro-related gene markers in a
medium-dependent manner (e.g., significant upregulation of BMP2, bone sialoprotein, osteocalcin, and Wnt5a
in BM2 condition). This has resulted in distinguished cell populations that were identifiable by specific gene sig-
natures as demonstrated by the principle component analysis. Through devitalization, mineralized carriers with
apatite crystal structures unique to each medium condition (by X-ray diffraction and SEM analysis) were
obtained. Quantitatively, BM3 condition produced carriers with the highest mineral and collagen contents as
well as human-specific VEGF proteins, followed by BM2 and BM1 conditions. Encouragingly, all mineralized
carriers (after reseeded with hPDCs) induced bone formation after 8 weeks of subcutaneous implantation in nude
mice models, with BM2-carriers inducing the highest bone volume, and the lowest in the BM3 condition (as
quantitated by nano-computed tomography [nano-CT]). Histological analysis revealed different bone formation
patterns, either bone ossicles containing bone marrow surrounding the scaffold struts (in BM2) or bone apposi-
tion directly on the struts’ surface (in BM1 and BM3). In conclusion, we have presented experimental data on the
feasibility to produce devitalized osteoinductive mineralized carriers by functionalizing 3D porous scaffolds with
an in vitro cell-made mineralized matrix under the mineralizing culture conditions.
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Introduction
Asuccessful repair of defected tissue/organ via tissueengineering approach requires the engineering of con-
structs with a high degree of biomimetic modalities that re-
capitulate the native tissue developmental process in an
in vivo recognizable and bioinstructive manner.1,2 These re-
quirements represent a unique scientific art to ‘‘decorate’’
synthetic constructs in vitro with crucial biological entities
that could timely promote construct viability, direct tissues
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growth, and subsequently integrate and function within the
host system. However, development of such ‘‘intelligent’’
construct is both scientifically and technologically challeng-
ing3 due to the high complexity of a biological system, and
hence hinders the identification of key biological elements
and their sequential events that are to be engineered.4
Recently, whole organ-derived decellularized extracellu-
lar matrix (ECM) has been explored as a native building
block to facilitate tissue/organ regeneration by combining
it with stem cells.5 It is hypothesized that the native ECM
provides a natural biological framework containing the nec-
essary bioactive motifs and microenvironment niche that
favor tissue growth.6 Indeed, this approach has shown reac-
tivation of specific organ functionalities, such as the in vitro
‘‘beating’’ of a heart after repopulating a decellularized heart
with predifferentiated contractile cells.7 Nevertheless, this
approach is not novel in the field of skeletal repair, where
demineralized bone matrix (DBM) has a long clinical track
record as bone filler8,9 and has also been widely investigated
as a tissue engineering carrier for bone defect repair.10–12
Unfortunately, the use of DBM (either xeno- or allogeneic)
has several drawbacks.8 To overcome these, scientists have
resorted to use in vitro cell culture–derived mineralized
ECM as possible alternative osteoinductive motif to func-
tionalize three-dimensional (3D) porous scaffolds.13 In
fact, enhanced osteogenic differentiation in vitro has been
reported14,15; however, the bone-forming capacity is so far
not apparent.16,17
It is known that bone matrix consists of mineralized colla-
gen fibers embedded with essential growth factors and trace
elements. This matrix is produced by osteoblastic cells
through specific physiological events,18,19 giving rise to a
unique biological architecture and mineralization hierar-
chy20,21 that governs its functionality and osteoinductivity.22
Introducing all these biomimetic features in a controlled way
through synthetic processing routes (such as biomimetic depo-
sition in simulated body fluid,23,24 electrolytic deposition,25,26
plasma spraying,27,28 and sol-gel29,30 techniques) remains
challenging, mainly due to the lack of in-depth knowledge
on the biological events and the limitations of existing techno-
logical tools.31–33 Recently, we have reported the feasibility to
use either Ca2+ or PO4
3 supplementation to produce living
3D osteogenic hybrids in vitro.34 However, simultaneous
use of Ca2 + and PO4
3 as mineralizing sources to function-
alize a bio-inert scaffold with highly mineralized ECM in
order to produce devitalized osteoinductive stem cells carri-
ers has not been explored. Therefore, in this study we aimed
at developing a so-called biomineralization medium (BM) to
promote in vitro cell proliferation, osteogenic differentiation,
and high bone-like ECM deposition on 3D porous scaffolds.
We anticipate that this approach may facilitate the produc-
tion of robust biomimetic mineralized carriers enriched
with natural cell adhesion peptides and osteoinductive motifs
that are minimally required to effectively emulate bone-spe-
cific cell–ECM interactions, eventually leading to osteogen-
esis preceded by matrix remodeling.
To test this hypothesis, simultaneous Ca2 + and PO4
3
supplementation in three medium formulations [i.e., in
growth medium (BM1), growth medium plus ascorbic acid
(BM2), and growth medium plus ascorbic acid plus dexa-
methasone (BM3); Table 1] were investigated using human
periosteal-derived progenitors (hPDCs) seeded on 3D open
porous, bio-inert Ti6Al4V (Ti)-scaffolds produced by addi-
tive manufacturing. This includes 3D hPDC proliferation
and osteochondro-related gene marker expression. After
devitalization, the microscopic mineral morphology, compo-
sition, and the presence of growth factors in the matrix ex-
tracts were assessed. The ectopic bone-forming capacity
was evaluated by subcutaneous implantation of hPDC-
reseeded mineralized carriers in nude mice for 8 weeks fol-
lowed by nano-CT quantification and histological analysis.
Materials and Methods
Materials
Calcium chloride (CaCl2$6H2O; Applichem), sodium di-
hydrogen phosphate dihydrate (NaH2PO4$2H2O; Merck),
di-sodium hydrogen phosphate dehydrate (Na2HPO4$2H2O;
Merck), dexamethasone (Sigma-Aldrich), and L-ascorbic
acid 2-phosphate sesquimagnesium hydrate (Sigma-Aldrich)
were purchased from the manufacturers. Center hollow (di-
ameter 2 mm), diamond unit cell, 3D open porous Ti6Al4V
(Ti)-scaffolds (diameter 6 mm · height 3 mm; pore size
1000 lm; porosity 93%) were designed using Magics soft-
ware (Materialise N.V.) and produced by selective laser
melting.35 The scaffolds were then cleaned with acetone,
96% ethanol, and demineralized water (each for 15 min)
using ultrasonic bath, followed by oxidation in 5 M NaOH
at 60C for 24 h and finally rinsed thoroughly with deminer-
alized water before sterilized by autoclaving. Prior to cell
seeding, the sterilized scaffolds were prewetted with culture
medium containing 10% fetal bovine serum (FBS) for 2 h,
and dried overnight in laminar flow under sterile condition.
Using computed tomography and image analysis techniques,
the sterilized scaffolds were reported to have an average pore
size of around 822lm and an average porosity of 81%.34
In vitro seeding and growth of hPDCs cultured
on Ti-scaffolds in various BM
Periosteal biopsies were harvested from the proximal tibia of
adolescent and adult patients during total knee replacement sur-
gery or distraction osteogenesis with patient informed consent
and approval by the ethics committee for Human Medical
Research of the University of Leuven. Briefly, after overnight di-
gestion of the biopsies in culture medium containing 0.2% type
Table 1. Composition of the Investigated
Biomineralization Media as Compared
to the Control Medium (GM¢ or OM) Without
Ca2 + and PO4
3 Supplementation
Treatment
Growth
medium
Ascorbic
acid
(50lg/ml)
Dexamethasone
(100 nM)
6mM
Ca2 + +
4mM
PO4
3
GM¢ + +  
OM + + + 
BM1 +   +
BM2 + +  +
BM3 + + + +
‘‘ + ’’ and ‘‘’’ indicate the presence and absence of the respective
chemical compounds.
BM, biomineralization media; GM, growth medium.
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IV collagenase (Invitrogen) at 37C, hPDCs were collected by
centrifugation and subsequently expanded in growth me-
dium (DMEM+10% FBS+1% antibiotics/antimycotics+ 1%
sodium pyruvate) using T-175 cm2 flasks. From passage 3
onward, the expanded cells were pooled together and stored
in liquid nitrogen. This cell type was reported by our research
group to have fibroblastic characteristic and possesses multi-
potent differentiation capacity of the mesenchymal stem cell
(MSC).36
For all assays in this study, hPDC pooled cells at early pas-
sage 4 (known to have higher homogeneity of MSC phenotype
and retains bone-forming capacity) were thawed from liquid ni-
trogen and expanded in growth medium using T-175 cm2 flask.
Upon confluence, the cells were harvested and drop-seeded
onto each scaffold (200,000 cells per scaffold), and incubated
for 1 h to allow cell attachment before transferred to a rotator
for overnight incubation in a cell culture incubator. This cell
seeding number was optimized in-house to allow for the obser-
vation of cell proliferation and ECM deposition on these partic-
ular scaffolds within the stipulated culture time under the
influence of the different medium used. Then, the samples
were transferred to 12-well suspension plate and cultured dy-
namically using a 3D rotator (30 rpm, Grant-Bio, UK). Calcium
(Ca2+ ) and phosphate (PO4
3) solutions (600 and 400 mM, re-
spectively) were prepared as described previously37 and diluted
100 times in the three medium formulations with the nomen-
clatures shown in Table 1. Cell proliferation in each medium
was assessed over 21 days of culture period by measuring the
metabolic activity using AlamarBlue (10% in growth medium,
Invitrogen) (n= 3), and DNA content using Quant-iT Pico-
Green dsDNA assay (Invitrogen) (n= 3). Cell viability of
hPDCs after 21 days of cultured under different biomin-
eralization media was qualitatively assessed using the
LIVE-DEAD viability assay kit (Life Technologies). Non-
ion-supplemented growth medium containing 50lg/ml
ascorbic acid (GM¢), or growth medium containing 50lg/
ml ascorbic acid and 100 nM dexamethasone (OM) were
used for comparison purposes.
Gene expression analysis of hPDCs 3D cultures
by quantitative real-time polymerase chain reaction
The expression of osteochondro-related gene markers by
hPDCs after cultured in various BM for 21 days was assessed
by quantitative real-time polymerase chain reaction (qRT-
PCR; n= 3). Briefly, cells were harvested in RLT buffer and
the total RNA of each sample was extracted using the RNeasy
mini kit (Qiagen) as per manufacturer’s instructions. The
amount of extracted RNA was measured using NanoDrop
(Thermo Scientific) and 500 ng of total RNA from each sample
was converted to cDNA using RevertAid First Strand cDNA
Synthesis kit (Thermo Scientific). qRT-PCR was cycled in a se-
quence detector (Rotor-Gene 6000; Corbett Life Science) using
SYBR Green primers as shown in Table 2. Each sample was
assessed in duplicate and compared with the housekeeping
gene b-actin expression (F5¢-CCCAGATCATGTTTGAGA
CCT-3¢; R5¢-CCTCGTAGATGGGCACAGT-3¢). Relative dif-
ferences in expression were calculated using the 2DCT method,
and statistical significance was calculated by comparing to the
2DCT of control medium (i.e., GM¢). In order to obtain more
comprehensive statistical information on the effects of BM
treatments on gene expression, principle component analysis
(PCA) was performed by loading the obtained gene expres-
sion data to the JMP analytical software (SAS Institute Inc.).
Then, a scatterplot was produced to visualize the specific
gene signatures that represent the induced cell populations
after the treatments.
Production of mineralized carriers by devitalization
and the mineralized ECM composition analysis
After 21 days of culture in various BM, the samples were
rinsed twice with phosphate buffered saline (Bio-Whittaker)
and stored at 80C in demineralized water under sterile
condition. To obtain devitalized mineralized carriers, the
samples were thawed from 80C to 37C and then sub-
jected to three cycles of freeze–thaw between liquid nitrogen
and 37C water bath (10 min each), followed by air-drying
overnight under sterile condition. Then, the devitalized min-
eralized carriers were stored at20C under sterile condition
till further analysis. The mineral phase, chemical composi-
tion, and microscopic morphology were characterized by
X-ray diffraction (XRD) analysis (Seifert XRD 3003 TT;
using a Cu K source in the 20–50 2h range; step size= 0.02;
slit size= 0.5 mm) and scanning electron microscopy coupled
with energy dispersive X-ray analysis (SEM-EDAX, XL30
FEG system; Philips) at 10 kV, respectively. The amount of
collagen and mineral contents deposited on Ti-scaffolds
Table 2. Primer Sequences Used for Gene Expression Analysis by Quantitative
Real-Time Polymerase Chain Reaction
Gene Forward sequence Reverse sequence
Runx2 5¢-CGCATTCCTCATCCCAGTAT-3¢ 5¢-GCCTGGGGTCTGTAATCTGA-3¢
Osx 5¢-AGTGACCTTTCAGCCTCCAA-3¢ 5¢-GGGAAAAGGGAGGGTAATCA-3¢
OCN 5¢-GTGCAGCCTTTGTGTCCAA-3¢ 5¢-GCTCACACACCTCCCTCCT-3¢
BMP2 5¢-GTACGCAGGCACTCAGGTC-3¢ 5¢-TTTTCCCACTCGTTTCTGGT-3¢
Wnt5a 5¢-GCTCCGCTCGGATTCCTC-3¢ 5¢- CCAATGGACTTCTTCATGGCG-3¢
VEGF 5¢-TGCAGATTATGCGGATCAAACC-3¢ 5¢-TGCATTCACATTTGTTGTGCTGTAG-3¢
BSP 5¢- GCCAGAGGAAGCAATCACCA-3¢ 5¢- TCATTGAGAAAGCACAGGCCA-3¢
Col1 5¢-GACGAAGACATCCCACCAAT-3¢ 5¢-AGATCACGTCATCGCACAAC-3¢
Col2 5¢-GGCTTCCATTTCAGCTATGG-3¢ 5¢-AGCTGCTTCGTCCAGATAGC-3¢
ALP 5¢-GGACATGCAGTACGAGCTGA-3¢ 5¢-GTCAATTCTGCCTCCTTCCA-3¢
RankL 5¢-CATCCCATCTGGTTCCCATAA-3¢ 5¢-GCCCAACCCCGATCATG-3¢
OPG 5¢-GGGGACCACAATGAACAACT-3¢ 5¢-AGCTGATGAGAGGTTTCTTCG-3¢
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under different medium conditions was assessed quantita-
tively using Picro-Sirius Red (1 mg/ml Sirius Red in satu-
rated Picric acid, n = 3) and Alizarin Red solutions (n = 3).34
Detection of secreted human-specific VEGF proteins
by Western blots
Devitalized mineralized carriers were thawed to room tem-
perature and the mineralized matrices were extracted from the
Ti-scaffolds using protein extraction buffer (0.3 M PMSF and
Protease Inhibition Cocktail; Sigma) under sonication on an
ice bath. For each condition, extracts from three samples
were pooled and the protein concentrations were determined
using the Pierce BCA Protein Assay Kit (Thermo Scientific).
Then, 5lg of extracted proteins was loaded onto a NuPAGE
4–12% Bis-Tris gel (Invitrogen) and thereafter transferred to a
polyvinylidene fluoride membrane. The membranes were in-
cubated with primary antibody–goat polyclonal anti-human
VEGF165 (1:1000; R&D Systems) according to the manufac-
turer’s instructions. HRP-conjugated secondary antibody
(Jackson) was used at a dilution of 1:2000 and images were
developed by an LAS3000 Imaging System (FUJI) following
the application of SuperSignal West Femto reagent (Thermo
Scientific). Densitometry analysis was performed using Bio-
Rad Quantity One software. Monoclonal antibody glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) (1:1000; Abcam)
was used to assess equal loading of proteins and to quantify
relative intensity of protein bands.
In vivo ectopic implantation of hPDC-reseeded
mineralized carriers
The bone-forming capacity of the mineralized carriers
produced under each culture conditions was evaluated by im-
plantation of hPDC-reseeded mineralized carriers in NMRI-
nu mice (female, 8 weeks) (three implants per mouse).
Briefly, 35ll of cell suspension containing 2 million
hPDCs at passage 4 (being the minimal cell number bench
mark used within our research group that is calculated
based on the corresponding scaffold volume to ensure bone
formation in vivo) was drop-seeded onto each carrier and in-
cubated for 1 h to allow cell attachment. Then, an additional
1 ml of growth medium was added and the samples were in-
cubated overnight on a rotator at 30 rpm before implantation
in subcutaneous pockets of the mice. The implantation pro-
cedures were approved by the local ethics committee for an-
imal research (KU Leuven) and adhered to the regulations of
animal housing according to the guidelines of the KU
Leuven Animalium.
Characterization of ectopic bone formation
by nanofocus X-ray computed tomography
and histological analysis
After 8 weeks of implantation, the samples were retrieved
and fixed in 4% paraformaldehyde solution for 2 h and stored
in phosphate buffered saline prior to nanofocus X-ray com-
puted tomography (nano-CT) analysis using Phoenix Nanotom
S system (GE Measurement and Control Solutions). The ex-
plants were scanned at an isotropic voxel size (3.125lm)3
using a tungsten target with the following parameters: volt-
age= 90 kV, current= 170lA, filter= 1 mm aluminum and
0.3 mm copper, exposure time= 500 ms, frame averaging= 1,
scanning time per sample= 20 min. Image reconstruction was
performed and analyzed using CTAn software (Skyscan NV),
by applying an in-house algorithm involving multilevel
thresholding, despeckling, and morphological operation with
dilation of scaffold volume in order to eliminate the partial
volume effect of the metallic materials and to segment out
the bone area for quantification of bone volume. Then, the
quantified bone volumes were subtracted with the background
values quantified for the controls (explants of nonmineralized
carriers obtained from GM¢ culture condition). For histologi-
cal analysis, the explants were embedded in poly-methyl
methacrylate resin, sectioned using a diamond saw (Leica),
and ground to approximately 70-lm-thick tissue sections. Ste-
venel’s Blue & Van Gieson’s picrofuchsin staining was used
to stain the bone and soft tissue structures.
Statistical analysis
All experiments were carried out in triplicate to assess
statistical significance, and the data are depicted as mean –
standard deviation (SD). Unpaired Student t-test (two-tailed)
was performed to compare means of two groups, whereas
one-way analysis of variance (ANOVA) followed by post-
hoc Tukey’s honest significant difference was used to per-
form multiple comparisons between the means of the exper-
imental conditions and the controls at each time point, by
establishing the statistical significance at p < 0.05. Statistical
significance is represented as follows: *p < 0.05, #p < 0.01,
and xp < 0.001.
Results
In vitro hPDC growth on 3D porous Ti-scaffolds
in the three formulated BM
As shown in Figure 1A, simultaneous Ca2 + and PO4
3
supplementation into growth medium (i.e., BM1) resulted
in the lowest metabolic activity over the 28 days of culture.
However, the metabolic activity was significantly enhanced
(especially at the later time points; p < 0.05) in the presence
of ascorbic acid (i.e., BM2) as compared to the control me-
dium (i.e., GM¢). In fact, the metabolic activity in BM2
reached a level that was comparable to culture condition con-
taining dexamethasone and ascorbic acid (i.e., OM) at 28
days. Encouragingly, culturing hPDCs in BM3 (supple-
mented with the ions, ascorbic acid, and dexamethasone)
resulted in the highest metabolic activity over 28 days
( p < 0.001 for each time point, respectively, as compared
to the control medium, GM¢). These data were confirmed
by the total DNA content measurement on samples harvested
at 28 days, where BM1 resulted in a significantly lower DNA
content ( p < 0.01), and BM2 and BM3 resulted in 1.5-fold
( p < 0.01) and 2.3-fold ( p < 0.001) higher DNA content
than GM¢, respectively (Fig. 1B). Brightfield microscopy
showed complete closure of the scaffold pores by mineral-
ized culture (*) under BM3 culture condition, and in a lesser
extent for BM1 and BM2 conditions (Fig. 1C). No mineral-
ization of cell cultures was observed in the control media (for
both GM¢ and OM). On the other hand, live–dead staining
showed high cell viability in BM2 and BM3 conditions (as
indicated by high green fluorescence-labeled cells), and rel-
atively more dead cells (red fluorescence-labeled cells,[)
were observed in BM1 condition.
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In vitro osteochondro-related gene markers expressions
by hPDC on Ti-Scaffolds in the three formulated BM
The effects of the formulated BM on osteogenic differ-
entiation, bone-like matrix production, and osteoclastic re-
cruitment activity were assessed at gene expression level by
qRT-PCR after 21 days of culture, as shown in Figure 2.
The results showed that simultaneous Ca2 + and PO4
3 sup-
plementation into the three culture media upregulated osteo-
genic differentiation markers, that is, osterix and Runx2, as
compared to the control medium, that is, GM¢ (Fig. 2A).
Interestingly, osterix expression was most significantly upre-
gulated ( p< 0.01) by the ion supplementation (i.e., BM1),
but was reduced in the presence of ascorbic acid (i.e.,
BM2) and dexamethasone (i.e., BM3). In contrast, ion sup-
plementation along with ascorbic acid and dexamethasone
(i.e., BM3) enhanced Runx2 expression ( p < 0.01), which
was significantly higher than the BM1 condition ( p < 0.05).
Additionally, bone sialoprotein (BSP), an osteogenic differ-
entiation and bone matrix marker, was highly upregulated
in the BM2 condition ( p < 0.001), but was differentially
downregulated in the BM3 condition ( p < 0.05) as compared
to GM¢.
Although osteocalcin (OCN) expression was increased in
BM2, it was not significantly different from the expression in
GM†, and the expression in BM1 but was significantly
higher than that of BM3 ( p < 0.05). BMP2 expression was
found to be significantly enhanced in the BM1 ( p < 0.05)
and BM2 ( p < 0.01) conditions, but no significant difference
was found between the expression in BM3 and GM¢ condi-
tions. Similarly, noncanonical Wnt ligand, that is, Wnt5a,
was significantly enhanced in BM1 and BM2 as compared
to BM3 and GM¢ conditions ( p < 0.01 for both cases). Fur-
thermore, gene expression analysis revealed a downregula-
tion of Col1 and ALP expressions in all the three BM as
compared to the control media (GM¢), with no significant ef-
fect on Col2 (Fig. 2B). Finally, culturing hPDCs in BM1 in-
duced the highest osteoclastic recruitment activity (as
indicated by the RankL:OPG ratio), followed by the BM2
condition, mainly due to a significant increase in RankL ex-
pression along with a significant decrease in the OPG ex-
pression in BM1 and BM2 as compared to GM¢ condition
(Fig. 2C).
PCA of the gene marker expression
Complementary, PCA showed that individual samples under
the same BM culture condition could be clustered together
according to their gene expression profile. Additionally, each
culture condition resulted in genetically distinguishable cell
populations (as indicated by the distances between the cell pop-
ulations on the PCA plot [Fig. 3A]) with highly upregulated
specific gene signatures (Fig. 3B). Specifically, BM1 treatment
induced a cell population that had a high RankL:OPG ratio and
FIG. 1. In vitro human periosteal-derived progenitor (hPDC) growth on Ti-scaffolds in different biomineralization medium
(BM). (A, B) The kinetics of metabolic activity over 28 days of culture and the total DNA content at 28 days, as compared
to the controls (i.e., GM¢ and OM). (C) The representative brightfield and fluorescence images showing different extent
of mineralization of hPDC cultures (*) and the living (stained green) and dead cells (stained red,[). Mean – SD (n= 3).
One-way analysis of variance (ANOVA) and post-hoc Tukey’s multiple comparison test: *p< 0.05, #p < 0.01, xp < 0.001;
n.s. = not significant.
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Osx expression, BM2-treated cells expressed high BSP, BMP2,
and Wnt5a, whereas BM3 treatment resulted in a cell popula-
tion represented by high expression of Runx2. On the other
hand, culturing hPDCs in control medium, that is, GM¢, induced
cell populations that mainly had high Col1 expression.
Characterization of the mineralized matrices
on devitalized carriers
After devitalization, gross observation showed that the
cellular structures of 3D hPDC cultures reduced in size and
FIG. 2. In vitro osteogenic-related markers’ expression of hPDCs on Ti-scaffolds after cultured in various BM condi-
tions for 21 days. (A) Osteogenic differentiation markers: osterix (Osx), Runt-related transcription factor-2 (Runx2),
bone sialoprotein (BSP), osteocalcin (OCN), bone morphogenetic protein-2 (BMP2), and wingless-type 5a ligand
(Wnt5a); (B) matrix and mineralization markers: collagen-type 1 (Col1), collagen-type 2 (Col2), and alkaline phosphatase
(ALP); (C) osteoclastic recruitment markers: receptor activator of nuclear factor kappa-B ligand (RankL), and osteopro-
tegerin (OPG). Mean – SD (n = 3). One-way ANOVA and post-hoc Tukey’s multiple comparison test: *p < 0.05, #p < 0.01,xp < 0.001; n.s. = not significant.
FIG. 3. Gene expression
profiles of different cell pop-
ulations after cultured in
biomineralization media for
21 days in vitro. (A) Principle
component analysis (PCA)
showing the clustering of
each samples under the same
culture condition and separa-
tion of the clusters according
to the treatments, and (B)
their gene signatures visual-
ized by the scatterplot.
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shrunk upon drying down to the surface of the Ti-scaffolds as
a relatively thin coating. Under brightfield microscopy, the
mineralized matrices (indicated by *) were found covering
the surface of the Ti-scaffolds at different degrees according
to the type of BM used (Fig. 4A). In fact, BM3 resulted in the
highest mineralized matrix deposition and homogeneity
throughout the scaffolds, followed by BM2 and BM1 condi-
tions, respectively. No mineralized matrix was found on the
control media, that is, GM¢. At higher magnification, these
matrices showed a different morphology, varying from
loose whitish patches (for BM1 and BM2) to a denser ap-
pearance (for BM3). Indeed, by SEM at high magnifica-
tion (10,000· ), agglomerates of mineralized matrix were
revealed in the BM1 condition, whereas BM2 and BM3
resulted in the formation of a mineralized matrix either
with plate-like crystals or aligned mineralized fibers, respec-
tively (Fig. 4B).
The deposition of the mineralized matrices was evi-
denced by EDAX analysis, where calcium and phosphorus
were found to be present within the matrices, whereas
ECM formed under GM¢ condition was not mineralized.
These findings were further supported by the XRD analysis
on the mineralized matrices, whereby peaks that are asso-
ciated with hydroxyapatite (reference number: 00-024-
0333) were found at 2h = 22.5, 25.9, 28.3, 31.7, and
45.9 (indicated byA) (Fig. 4C). These peaks were absent
in the nonmineralized matrices formed under GM¢ condi-
tion. By Alizarin Red and Picro-Sirius Red stainings, the
highest mineral and collagen contents were quantitated in
samples derived from BM3 condition ( p < 0.05 in both
FIG. 4. Characterization of the deposited mineralized matrices on the devitalized carriers. (A) Representative brightfield
microscopic images showing the morphology and distribution of the mineralized matrices that were deposited on the Ti-
scaffolds. (B) By SEM (at 10,000 magnification), the mineralized matrices were revealed to have different morphology,
varying from agglomerates to plate-like crystals and highly organized parallel mineralized fibers. EDAX analysis sug-
gested the deposition of Ca2 + and PO4
3 containing minerals. (C) XRD analysis confirmed the deposition of apatites in-
dicated by the presence of peaks at 22.5, 25.9, 28.3, 31,7, and 45.9. (D) Alizarin Red and Picro-Sirius Red staining and
quantification showed the deposition of mineralized collagenous matrices on the porous Ti-scaffolds, with BM3
resulting in the highest mineralized matrix content. Mean – SD (n = 3). Unpaired Student t-test (two-tailed): *p < 0.05;
n.s. = not significant.
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cases as compared to BM1), followed by BM2 and BM1
(Fig. 4D).
VEGF gene expression and protein levels in the extracts
of devitalized mineralized matrices
As shown in Figure 5A, gene expression analysis revealed
upregulation of VEGF expression by hPDCs after cultured in
the three formulated BM for 21 days, whereby BM3 condi-
tion resulted in significantly higher gene expression than
the control medium (i.e., GM¢). However, no statistical dif-
ference in the gene expression levels between the three for-
mulated BM was observed. Nevertheless, human-specific
VEGF165 subtype protein was detected in the extracts of
the devitalized mineralized matrices by Western blotting,
and quantification of the relative intensities (normalized to
the intensities of GAPDH) showed that BM3 induced
the highest protein expression, where the protein level by
the BM2 condition was statistically not different from the
GM¢. No Western blot was performed for extract of the
BM1 condition due to low amount of the extracted total pro-
teins in the samples.
In vivo ectopic bone induction by hPDC-reseeded,
devitalized mineralized carriers
After 8 weeks of subcutaneous implantation, nano-CT
image analysis showed that all devitalized mineralized carri-
ers induced ectopic bone formation (indicated as orange
structures in pseudocolor or labeled as ‘‘B’’), except for
the nonmineralized carriers obtained from the control condi-
tion, that is, GM¢ (Fig. 6A). The newly formed bone was ei-
ther in direct contact with the surface of the scaffold (labeled
as ‘‘Ti’’) or formed bone ossicles that surrounded the scaf-
fold struts. Nano-CT quantification revealed the highest
bone volume induction by carriers obtained from the BM2
condition, followed by BM1, whereas carriers produced in
the BM3 condition induced the lowest bone volume, which
was significantly lower ( p< 0.05) than that produced in
BM2 (shown by the box-plots in Fig. 6B). However, none
of the conditions induced homogeneous bone formation
throughout the scaffolds as indicated by the sagittal, transax-
ial, and coronal planes of the 2D (Fig. 6C) and 3D (Fig. 6D)
reconstructed nano-CT images.
The formed bone was found at discrete locations mainly at
the top or bottom section of the scaffold (with columnar
channels), and in lesser extent at the center section of the
scaffold (with diamond unit cell). These findings were cor-
roborated by histological staining of the resin-embedded sec-
tions using Stevenel’s Blue and picrofuchsin solutions (Fig.
7), whereby bone (‘‘B,’’ stained in red color) was found ei-
ther deposited on the scaffold surface or surrounding the
scaffold struts. Interestingly, a bone marrow compartment
(labeled as ‘‘m’’) in between the bone tissue and the scaffold
was observed only on carriers obtained from BM2. No bone
was observed in nonmineralized carriers (i.e., carriers pro-
duced in GM¢); instead, only soft tissues (labeled as ‘‘st’’)
was evidenced. Finally, no sign of inflammation or foreign
body reaction was observed in any of the explants.
Discussion
In this study, we presented experimental data on the feasi-
bility to produce devitalized osteoinductive mineralized car-
riers by functionalizing 3D porous scaffolds with an in vitro
cell-made mineralized matrix under mineralizing culture
conditions. Our ultimate goal is to produce off-the-shelf bio-
mimetic mineralized carriers for autologous stem cell im-
plantation in order to effectively mediate bone regeneration
in the clinic. Indeed, there are established research find-
ings evidencing the osteoinductivity of calcium phosphate-
containing or mineralized biomaterials,32,38,39 especially
when the intramembranous ossification pathway is adopted
as a bone engineering strategy.40 Nevertheless, in order to
achieve optimal bone-forming capacity, the type of calcium
phosphate or mineralized matrix used is crucial to ensure a
good match with the targeted cell type.33,41 Therefore, it is
a reasonable approach that if cells secrete and build their
very-own mineralized matrix, this matrix will be more phys-
iological and cell type-customized than a generic, syn-
thetic matrix in terms of improving in vivo recognition,
bone tissue induction, and implant integration into the host
environment.1,2,4
In general, standard osteogenic medium that contains b-
glycerophosphate (as mineral source) is used to promote
mineralized ECM deposition in vitro. Although several
recent studies have reported encouraging in vitro osteo-
genic differentiation effects, the in vivo bone-forming capacity
FIG. 5. (A) VEGF gene expres-
sion levels of hPDCs quantified by
qRT-PCR after cultured in various
BM for 21 days as compared to the
control medium, GM¢. Unpaired
Student t-test (two-tailed): *p< 0.05;
n.s.= not significant. (B) VEGF
protein levels deposited in the min-
eralized matrix of the devitalized
carriers obtained from various BM
conditions by Western blot tech-
nique. qRT-PCR, quantitative real-
time polymerase chain reaction.
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of these constructs was not apparent.16,17 Based on this jus-
tification and our previous research findings on single
ion-instructed cell proliferation and mineralized matrix for-
mation,34 we hypothesized that supplementing Ca2 + and
PO4
3 to a culture medium simultaneously would be favor-
able to the cells to self-modulate the uptake of the ions for
mineralization of the cell-secreted ECM. The same opinion
stands for studies that adopted an ion-enriched culture envi-
ronment to direct nucleation of mineralizing ions onto the
collagen fibers.21,42
In fact, our current findings clearly showed that cell prolif-
eration was not compromised by the ions supplementation,
and was significantly enhanced by adding ascorbic acid
and further amplified by dexamethasone (which has been
reported to induce a burst of proliferation in a cohort of
cells that undergo differentiation43). This significant mito-
genic effect also resulted in a complete closure of the scaf-
fold pores where the highest cell proliferation was
observed, indicating the feasibility to obtain carriers fully
filled with cells and mineralized ECM. However, the depos-
ited cellular structures reduced in size after devitalization
and shrank to the surface of the Ti-scaffolds as a relatively
thin coating upon drying, giving rise to an open porous min-
eralized carrier with minimal changes on the porosity and
pore size. Nevertheless, this porous feature has crucial
importance as a stem cell carrier to allow for high cell re-
seeding efficiency and to provide sufficient void volume
for in vivo bone tissue formation inside the carrier.
Subsequently, we investigated the differentiation stage of
hPDCs under the different mineralizing culture conditions
through gene expression analysis. These data are of utmost
importance as they provide information that reflects the
osteogenicity of the deposited mineralized matrices due to
different matrix compositions under the influences of the dif-
ferent culture media used. Specifically, addition of dexa-
methasone and ascorbic acid into the ion-supplemented
medium (i.e., BM3) resulted in highly expressed Runx2 but
significantly lower OCN, BSP, and BMP2 expressions.
FIG. 6. In vivo ectopic osteoinduction by hPDC-reseeded devitalized mineralized carriers. (A) Nano-computed tomogra-
phy (nano-CT) 2D images showing bone tissues (indicated as ‘‘B’’ for orange areas) formed on all the three formulated BM
either deposited on or surrounded the scaffold struts (indicated as ‘‘Ti’’) (see insets). No bone formation was induced in the
control condition, that is, GM¢. (B) Box-plots showing highest bone volume was induced by carriers produced in BM2 con-
dition, followed by BM1, and the lowest in BM3 as quantified by nano-CT analysis (unpaired Student t-test [two-tailed]:
*p < 0.05; n.s. = not significant). (C, D) The sagittal, transaxial, and coronal planes of representative 2D and 3D reconstructed
nano-CT images revealed inhomogeneous distribution of bone formation on the scaffolds, whereby the bone tissues were
mainly found at the top or bottom section of the scaffold (with columnar channels) and in lesser extent at the center part
of the scaffold (with diamond unit cell). Scale bar= 1 mm.
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This may indicate an enriching effect of osteochondroproge-
nitors on hPDCs by dexamethasone rather than differentiat-
ing the cells into a later stage of the osteogenic lineage.44
Interestingly, no significant difference in Col2 expression
(a chondrogenic matrix marker) was observed in this culture
condition. Without dexamethasone, culturing hPDCs in ion-
supplemented medium with ascorbic acid (i.e., BM2)
resulted in a significant upregulation of BSP and BMP2 ex-
pression, whereas purely ion-supplemented medium (i.e.,
BM1) may predispose the hPDCs toward a more advanced
commitment in the osteogenic lineage as suggested by the
upregulation of Osx.
It is known that BSP, consisting of 12% of the noncollag-
enous protein in human bone, acts as a nucleator of hydroxy-
apatite, and mediates cell metastasis on the bone surface via
vitronectin receptor.45 In fact, BSP deficiency impairs bone
growth and mineralization, concomitant with dramatically
reduced bone formation.46 Similarly, BMP2 expression (a
potent bone inducer) was significantly upregulated in the
BM2 condition, which may be another important contributor
to the osteogenicity of the produced mineralized carriers. It is
also interesting to observed that the up- and downregulation
of BMP2 expression coincided with the significant upregula-
tion of Osx (activated upon BMP/p38 signaling47) in the
BM1 and BM2 conditions, and the significant upregulation
of Runx2 in BM3 as BMP2 was reported as a suppressor of
Runx2.48 Nevertheless, the observed in vitro gene expression
responses were solely due to the different culture media for-
mulations, whereas the in vivo bone formation outcomes
could be influenced by various factors present on the pro-
duced mineralized carriers. These include the differences
in substrate chemistry, surface roughness, porosity, as well
as the cell–material–host interaction by the reseeded cells
(such as implanted cell survival and differentiation into
bone-forming cells in vivo, as well as their effect on early in-
flammation),40,49 and the deposited proteins/growth factors.
Furthermore, the significant upregulation of Wnt5a ligand
(associated to noncanonical Wnt-Ca2+ signaling) in the BM1
and BM2 conditions may be due to the Ca2+ -enriched culture
environments. The biological effect of Wnt5a on osteogenic
differentiation and bone formation is unclear.50 For instance,
Wnt5a has been reported to induce osteoblastogenesis in bone
marrow MSCs,51 but also to inhibit bone formation by promot-
ing GSK-3-independent b-catenin degradation.52 Interestingly,
Col1 expression was downregulated in all culture conditions,
as well as the mineralization regulator, ALP. The downregula-
tion of ALP could be attributed to a negative feedback on ALP
expression under a high free PO4
3 culture environment.53
Both BM1 and BM2 conditions also induced significantly
higher osteoclastic recruitment activity (as indicated by the in-
crease in the RanKL:OPG ratio), probably a response by hPDCs
in confrontation with a mineralizing culture condition.40
Finally, VEGF expression was upregulated in all BM con-
ditions as compared to the control medium, and BM3
resulted in the most pronounced expression levels. This phe-
nomenon could be related to the upregulation of Runx2 under
the BM3 condition, which has been reported as a necessary
component for VEGF expression.54 This finding was corrob-
orated by the Western blot analysis whereby human-specific
VEGF165 subtype (an ECM-bound protein) was detected to
be the highest in the extract of the mineralized matrix
obtained from BM3.
The state-of-the-art decellularization method using a de-
tergent was not adopted in this study, although it has been
reported to be superior in obtaining a cell-/DNA-free
ECM.55,56 The main reason was to avoid any potential risk
of denaturation of proteins or growth factors that might be se-
creted by the cells onto the mineralized matrix, which may
be the key determinant(s) of osteoinduction of the produced
carriers.57 Therefore, a more gentle devitalization method
was performed to lyse cells using three freeze–thaw cycles
meanwhile preventing denaturation of the mineralized ma-
trix and the secreted matrix-bound growth factors.58 The
use of different BM resulted in distinctly different mineral
matrix morphologies (from agglomerates to plate-like and
parallel mineralized fiber-like) as shown by brightfield mi-
croscopy and SEM. This is believed to be attributed to the
use of ascorbic acid and/or dexamethasone that are both
known to promote collagen synthesis, alkaline phosphatase
FIG. 7. Histological images showing bone tissue forma-
tion (indicated by arrow heads or labeled as ‘‘B’’) either in
direct contact with the scaffold surface (labeled as ‘‘Ti’’)
(in BM1 and BM3 conditions), or bone ossicles containing
bone marrow (indicated as ‘‘m’’) surrounded the scaffold
struts (in BM2 condition). Stevenel’s Blue and picrofuchsin
staining; st= soft tissues; ‘‘[’’ indicates osteocytes.
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activity, and osteochondrogenic differentiation of hPDCs,27
as well as their interactions with the supplemented Ca2 +
and PO4
3 ions.
Altogether, this might have resulted in different cell differ-
entiation stages, different dynamics of the mineralization pro-
cess, and different matrix compositions.59,60 Different mineral
morphologies could give rise to different physicochemical
properties (including ion dissolution kinetics and surface
roughness) that have been reported to have significant impact
on in vitro cellular proliferation and differentiation as well as
the in vivo osteoinductivity.32,33 Unfortunately, assessment of
the surface roughness by conventional technique such as
atomic force microscopy on 3D scaffold61 with limited flat
surface is technically impossible. Furthermore, the deposited
mineralized matrices were not homogenously distributed
throughout the scaffolds; therefore, the assessment of surface
roughness by other technique, such as computed tomography
plus image analysis,62 will not be representative. Thus, the ef-
fect of surface roughness on the biological outcomes could not
be assessed in this study.
Encouragingly, reseeding hPDCs onto all devitalized,
mineralized carriers induced ectopic bone formation after 8
weeks of implantation. By nano-CT image analysis and
quantification, BM2 induced the highest bone volume, fol-
lowed by BM1 and BM3. However, the percentage of bone
formed within all the carriers was relatively low (approxima-
tely 0.5–1% of the total scaffold pore volume [64.8–
1.96 mm3]). Inhomogeneous bone distribution within the
scaffolds was most likely a result of inhomogeneity of min-
eralized matrix deposition (especially after devitalization),
although a relatively high porosity and pore size of scaffold
structure was used in this study under a shaking culture con-
dition. This prompts the need to improve the mineralized ma-
trix deposition throughout the scaffolds, for example, by
perfusing BM through the scaffold in a controlled manner
via a 3D perfusion bioreactor or by optimizing the scaffold
properties through the study of the effect of the porous Ti-
scaffold intrinsic properties (such as pore geometry, pore
size, porosity, surface roughness, and chemistries) on miner-
alization of hPDCs.63
Additionally, we believe that the presence of bone–bone
marrow entity formation in the BM2 condition could be re-
lated to the upregulation of BMP2 expression, as BMP upre-
gulation is associated with the observed bone-forming
pattern.64,65 This correlation can be further strengthened, as
no bone marrow compartments were found by histological
analysis in carriers produced by BM3, where BMP2 expres-
sion was also significantly downregulated. The direct bone–
titanium interface contacts indicated that in vivo biomechan-
ical stability may be provided by the carriers to promote
osseointegration.
Conclusions
In this study, we provided important biological insights on
the effects of the studied BM on in vitro osteoprogenitor pro-
liferation, osteogenic differentiation, and mineralized matrix
deposition to functionalize 3D open porous scaffolds. Addi-
tionally, we demonstrated the feasibility to obtain devitalized
mineralized carries that have different mineral morphologies
and matrix composition, as well as a culture-dependent bone-
forming capacity after reseeding hPDCs onto these carriers.
This may represent a novel approach to produce highly bio-
mimetic, mineralized tissue engineering constructs that hold
potential as off-the-shelf stem cell carriers that could
effectively mediate bone defect repair or regeneration in
the clinic.
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